Website-Page-Photos-13

A BETTER WAY
TO MANAGE
PHARMACY BENEFITS


The PBM Partner Employers Deserve

Learn More About Us
Untitled-design-7


Best-in-Class Fully Bundled Solution for Employers

Specialized solution for emerging and mid-market employer groups

Innovative program package built to manage costs

Full service, in-house pharmacy benefit management


Untitled-design-6


High-Touch, High-Quality Service in Every Interaction

We treat members like family, with care and integrity.

We partner closely with our clients and advisors, working as one team with proactive and timely communication.

The best way to describe the EpiphanyRx team? Servants at heart.


Untitled-design-8-1


Transparency = Table Stakes

100% pass through of drug discounts  

100% pass through of rebates  

No conflicts of interest like spread pricing or rebate retention  


News & Insights

The Fast Five: Data Decoded – The Right Kind of Reporting

Employers are tired of feeling confused or overwhelmed by the data provided from their pharmacy benefit manager (PBM). In our latest Fast Five post, we’re uncovering what makes up a stellar reporting package from a PBM, including essential data points for employer groups and the pitfalls of overwhelming clients with too much data.

The Fast Five: Data Decoded – The Right Kind of Reporting
The Fast Five: Change Is Good. How a Member- and Client-Centric PBM Manages Transition

We’ve been seeing employers hesitate to move to a new pharmacy benefit manager (PBM) for fear of the impact on their members. In this Fast Five, we share what it’s really like for employers and their employees to move to a better PBM (like EpiphanyRx) with a supportive transition approach.

The Fast Five: Change Is Good. How a Member- and Client-Centric PBM Manages Transition
WHITE PAPER: ADHD Medication Trends

EpiphanyRx performed a study to identify drivers contributing to recent increased ADHD medication use within commercial employer groups. Read more about our discoveries.

WHITE PAPER: ADHD Medication Trends
The Fast Five: Still Buzzing About Biosimilars

In this Fast Five, we revisit biosimilars - still a hot industry topic. We explore biosimilar pricing and the incentives motivating drug manufacturers and pharmacy benefit managers (PBMs). We discuss formulary decisions including placement of biosimilars and removal of brand Humira®. To help us break down this complicated topic, we consulted our clinical expert, Janelle Sheen, Senior Director of Clinical Strategy.

The Fast Five: Still Buzzing About Biosimilars
The Fast Five: Transparency in the Age of GPOs

GPOs began emerging in 2019 and continue to grow. In this Fast Five, we share five insights on transparency in the age of GPOs and what to keep in mind when you are evaluating different PBMs. 

The Fast Five: Transparency in the Age of GPOs
WHITE PAPER: Impact of Preventive Medication on Pharmacy Benefit Plan Selection

EpiphanyRx studied the refill success rates for preventive medications as a measure of adherence in HDHPs across our book of business. Learn more about what we discovered.

WHITE PAPER: Impact of Preventive Medication on Pharmacy Benefit Plan Selection

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×